Recombinant enzyme prepared from insect cells infected with baculovirus containing human UGT1A10 cDNAs

UDP-glucuronosyltransferases (UGT) represent the major phase II drug metabolism pathway in human. UGT enzymes catalyze the transfer of glucuronic acid (derived from UDPGA co-factor) to xenobiotics and endogenous substrates having nucleophilic acceptor groups, making them more polar and readily excreted in urine or bile. To date, at least 18 human UGT enzymes have been cloned and sequenced. Like the P450 enzymes, UGTs possess broad and overlapping substrate specificities. Clinically relevant drug interactions have been identified for UGT isoforms, leading regulatory agencies (FDA) to require drug interaction testing for compounds showing significant UGT metabolism.

UGT1A10 is an extra-hepatic isoform, with highest expression levels in the in gastrointestinal tissue, e.g., stomach, small intestine, and colon. UGT1A10 has been shown to glucuronidate several drug substrates, e.g. troglitazone, raloxifene, mycophenolic acid.

Available size: 0.5 mL

Protein concentration: 5 mg/ mL

Product Number

456410

Qty./Pk

1?/ Pk

Qty./Cs

1?/ Ea

Brand

Corning?

Size

0.5 mL

Species

Human

Enzyme Type

UGT

Protein Concentration

5 mg/mL

Storage

-80 C

Cellular Location

Microsome